Taiko Pharmaceutical Co., Ltd. Financial Overview
Taiko Pharmaceutical Co., Ltd.'s market cap is currently ¥14.87B. The company's EPS TTM is ¥7.76; its P/E ratio is 17.49; Taiko Pharmaceutical Co., Ltd. is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
